KYOWA KIRIN CO., LTD.

KYOWA KIRIN CO., LTD. logo
πŸ‡―πŸ‡΅Japan
Ownership
Public, Subsidiary
Established
1949-07-01
Employees
5.9K
Market Cap
-
Website
http://www.kyowa-kirin.co.jp

Study of KW-0761 in Subjects With CCR4-positive Peripheral T/NK-cell Lymphoma

Phase 2
Completed
Conditions
Interventions
First Posted Date
2010-09-01
Last Posted Date
2017-03-03
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
38
Registration Number
NCT01192984
Locations
πŸ‡―πŸ‡΅

University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan

πŸ‡―πŸ‡΅

Nagasaki University Hospital, Nagasaki, Japan

πŸ‡―πŸ‡΅

Okayama University Hospital, Okayama, Japan

and more 12 locations

A Phase 3 Study of OPC-262 in Patients With Type 2 Diabetes

Phase 3
Completed
Conditions
Interventions
First Posted Date
2010-09-01
Last Posted Date
2014-01-08
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
450
Registration Number
NCT01193179

Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15

First Posted Date
2010-08-02
Last Posted Date
2017-03-30
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
44
Registration Number
NCT01173887
Locations
πŸ‡―πŸ‡΅

Imamura Bun-in Hospital, Kagoshima, Japan

πŸ‡―πŸ‡΅

Kagoshima University Hospital, Kagoshima, Japan

πŸ‡―πŸ‡΅

Kokura Memorial Hospital, Kitakyushu, Japan

and more 16 locations

A Clinical Pharmacology Study of Saxagliptin in Patients With Type 2 Diabetes Mellitus

Phase 3
Completed
Conditions
Interventions
First Posted Date
2010-07-15
Last Posted Date
2017-03-09
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
20
Registration Number
NCT01162876
Locations
πŸ‡―πŸ‡΅

Kyushu Clinical Pharmacology Reserch Clinic, Fukuoka, Japan

Study of ARQ 197 Monotherapy

Phase 2
Completed
Conditions
Interventions
First Posted Date
2010-06-29
Last Posted Date
2017-03-15
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
31
Registration Number
NCT01152645

Effect of External Heat on a Transdermal Granisetron Patch in Pharmacokinetics (PK) of Healthy Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2010-02-23
Last Posted Date
2024-06-17
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
16
Registration Number
NCT01073696
Locations
πŸ‡¬πŸ‡§

Quotient Clinical Limited, Edinburgh, United Kingdom

A Study of ARQ 197 in Combination With Erlotinib

Phase 1
Completed
Conditions
Interventions
First Posted Date
2010-02-17
Last Posted Date
2017-03-15
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
16
Registration Number
NCT01069757

A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma

Phase 1
Completed
Conditions
Interventions
First Posted Date
2010-02-05
Last Posted Date
2024-04-25
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
95
Registration Number
NCT01063907
Locations
πŸ‡ΊπŸ‡Έ

Arizona Clinical Research Center, Inc. / Arizona Oncology Associates, 1825 N Kolb,, Tucson, Arizona, United States

πŸ‡ΊπŸ‡Έ

Pacific Shores Medical Group 1043 Elm Ave, Suite 104, Long Beach, California, United States

πŸ‡ΊπŸ‡Έ

Collaborative Research Group 2320 S Seacrest Blvd, Suite 202, Boynton Beach, Florida, United States

and more 23 locations

Extended Long-Term Safety Study of KW-6500

Phase 3
Completed
Conditions
Interventions
First Posted Date
2010-02-05
Last Posted Date
2017-03-15
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
27
Registration Number
NCT01063621

Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500

Phase 3
Completed
Conditions
Interventions
First Posted Date
2010-01-28
Last Posted Date
2017-03-03
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
31
Registration Number
NCT01058291
Locations
πŸ‡―πŸ‡΅

Ehime University Hospital, Toon, Ehime, Japan

Β© Copyright 2024. All Rights Reserved by MedPath